<DOC>
	<DOC>NCT02062658</DOC>
	<brief_summary>This study investigates if a single dose of IV Ketamine can rapidly improve Obsessive-Compulsive Disorder (OCD) symptoms and whether these effect can be maintained with a condensed course of a type of Cognitive Behavioral Therapy called Exposure and Response Prevention (EX/RP). You will be compensated for your time and travel. Participants must be between the ages of 18-55.</brief_summary>
	<brief_title>Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)</brief_title>
	<detailed_description />
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Age 1855 Physically healthy and not currently pregnant Primary Diagnosis of OCD Sufficient severity of symptoms Currently off all psychotropic medication OR Currently on adequate dose of medication for treatment of OCD, but have not achieved at least partial remission Able to provide consent Psychiatric conditions that make participation unsafe (schizophrenia [either self or first degree relative e.g. siblings, parents], history of violence, severe depression, eating disorder, substance dependence [including nicotine]) Female patients who are either pregnant or nursing Planning to commence EX/RP during the period of the study or those who have completed an adequate dose of EX/RP (defined as 8 or more sessions within 2 months) within 8 weeks prior to enrollment. period of the study Allergy to ketamine Participants for whom being off of medication is not clinically recommended Medical conditions that make participation unsafe (e.g. high blood pressure, head injury) Currently on medications that make participation unsafe</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>OCD</keyword>
</DOC>